Research Article

AHCYL1 Is a Novel Biomarker for Predicting Prognosis and Immunotherapy Response in Colorectal Cancer

Figure 6

Relationship among risk model, TMB, TIDE, and immunotherapy response to CRC patients. (a) Correlation analysis to analyze the correlation between target gene AHCYL1 and its related prognostic genes in CRC. (b) The TMB in different risk groups. (c) The value of the TIDE from TCGA database. (d) The response to immunotherapy from TCGA database. (e) The value of the TIDE from ICGC database ().
(a)
(b)
(c)
(d)